Australia - English - Department of Health (Therapeutic Goods Administration)

pacific dental specialties pty ltd - 46122 - dental implant suprastructure device, temporary, reusable - analogs are intended for simulation of dental implant connection and position on a stone or resin master model. transfers are intended for the transfer of implant position from the intraoral situation to the model in dental laboratory.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - emedastine difumarate 0.884mg/ml eqv to emedastine - solution, sterile - 0.5mg/ml - emedastine difumarate 0.884mg/ml eqv to emedastine 0.5mg/ml

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - intravenous or intramuscular injection  when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: •  endocrine disorders            primary or secondary adrenocortical insufficiency(hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular  importance)            acute adrenocortical insufficiency(hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when syntheticanalogs are used)            preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - intravenous or intramuscular injection  when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: •  endocrine disorders            primary or secondary adrenocortical insufficiency(hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular  importance)            acute adrenocortical insufficiency(hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when syntheticanalogs are used)            preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful            shock unresponsive to conventional therapy if a

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methylprednisolone acetate 40 mg/ml - injection (depot) - 40 mg/ml - active: methylprednisolone acetate 40 mg/ml excipient: hydrochloric acid macrogol 3350 miripirium chloride sodium chloride sodium hydroxide water for injection - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy; mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). congenital adrenal hyperplasia. hypercalcemia associated with cancer. nonsuppurative thyroiditis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methylprednisolone 100mg - tablet - 100 mg - active: methylprednisolone 100mg - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). · congenital adrenal hyperplasia. · nonsuppurative thyroiditis · hypercalcemia associated with cancer

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methylprednisolone 4mg; methylprednisolone 4mg - tablet - 4 mg - active: methylprednisolone 4mg excipient: calcium stearate lactose monohydrate liquid paraffin purified water sucrose active: methylprednisolone 4mg excipient: calcium stearate lactose monohydrate maize starch purified water sucrose - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). · congenital adrenal hyperplasia. · nonsuppurative thyroiditis · hypercalcemia associated with cancer

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride; glucose; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.4 g/l; magnesium chloride 0.051 g/l; calcium chloride 0.184 g/l; glucose as monohydrate 15 g/l; glucose 13.6 g/l; lactic acid as sodium 4.5 g/l - isotonic solutions - for peritoneal dialysis including acute and chronic renal failure, severe water retention, electrolyte disorders, drug intoxication.

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride; glucose; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose 38.6 g/l; lactic acid as sodium 4.5 g/l; glucose as monohydrate 42.5 g/l; magnesium chloride 0.051 g/l; sodium chloride 5.4 g/l; calcium chloride 0.184 g/l - isotonic solutions - indicated whenever peritoneal dialysis is employed including acute and chronic renal failure, severe water retention, electrolyte disorders, drug intoxication.

Singapore - English - HSA (Health Sciences Authority)

lotus international pte. ltd. - ixabepilone - injection, powder, lyophilized, for solution - 15 mg/vial - ixabepilone 15 mg/vial